供应链

Japanese pharma boss rules out China exit after executive’s arrest
日本药企安斯泰来在高管被捕后排除退出manbetx3.0

Astellas CEO says company will diversify supply chains in first comments since employee’s detention
安斯泰来CEO冈村直树在公司驻华高管因涉嫌从事间谍活动被捕后首次公开表态,称这起事件不应促使该公司缩减在华业务。

The chief executive of Astellas has ruled out an exit from China after Beijing detained a local executive of the company last month, a move that sent shockwaves through the Japanese business community in the country.In his first public comments since its employee was arrested in late March on espionage charges, Naoki Okamura said Japan’s second-largest pharmaceutical company by revenue planned to take further steps to diversify its supply chain in China, but cautioned against the incident becoming a catalyst to pull back its presence.

安斯泰来(Astellas)的首席执行官排除了退出manbetx3.0 的可能性,此前北京方面上月拘留这家日本制药企业的一名在华高管,此举震惊了日本商界。

您已阅读9%(608字),剩余91%(6099字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×